Search

Hutchison China MediTech Ltd ADR

Fermé

SecteurSoins de santé

12.4 0.4

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.72

Max

12.42

Chiffres clés

By Trading Economics

Revenu

-8.9M

-8M

Ventes

3.7M

139M

P/E

Moyenne du Secteur

121.8

57.366

Marge bénéficiaire

-5.724

Employés

1,790

EBITDA

18M

4M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+18.52% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

205M

2.1B

Ouverture précédente

12

Clôture précédente

12.4

Sentiment de l'Actualité

By Acuity

100%

0%

325 / 340 Classement par Healthcare

Hutchison China MediTech Ltd ADR Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 août 2026, 23:56 UTC

News

Constellation Brands reported first-quarter results that beat expectations, driven by beer sales. The company also reaffirmed EPS guidance and plans a $100 million investment.

26 août 2026, 23:31 UTC

Correlated Moves
News

The Canadian dollar weakened as Canada imposed $20 billion in tariffs on U.S. goods, contributing to negative sentiment amid ongoing U.S. inflation pressures.

26 août 2026, 23:31 UTC

News

Interactive Brokers Group shares declined in after-market trading following a Market Perform rating from Raymond James analyst Tim DeLacey. The stock pulled back after earlier gains.

26 août 2026, 23:26 UTC

News

Zebra Technologies is higher in after-market trading, following its TestMu Conference presentation and analyst estimates valuing shares at $399.00, above the last close of $360.52.

26 août 2026, 23:21 UTC

News
Social Media

Oppenheimer raised Revolution Medicines' price target to $260, citing FDA approval of RASONQUE for advanced pancreatic cancer, as shares trade higher in after-market hours.

26 août 2026, 23:16 UTC

Correlated Moves
News

Oracle Corp shares rise in after-market trading following strong fiscal fourth-quarter results, including a 93% increase in cloud-infrastructure revenue to $5.8 billion.

26 août 2026, 23:06 UTC

News
Social Media

Amazon.com Inc announced a major expansion with Nvidia to deploy 2 million additional GPUs across AWS by 2027-2028, driving shares higher in after-market hours.

26 août 2026, 23:06 UTC

News
Social Media

Bill Gates emphasized AI risks in a recent essay, urging stronger controls. Microsoft remains roughly flat after deciding against a cloud facility in West Virginia.

26 août 2026, 23:06 UTC

Correlated Moves
News

Box shares are higher in after-market trading, buoyed by broader market sentiment and Salesforce's significant price movement. Management will present at Citi’s TMT Conference in 2026.

26 août 2026, 23:06 UTC

Correlated Moves
News

Intuit Inc reported second-quarter revenue of $4.35 billion, exceeding estimates. Shares are trading higher in after-market hours following the results.

26 août 2026, 23:02 UTC

News
Event

Ooma Inc reported fiscal Q2 revenue of $83.2 million, exceeding estimates. Shares advanced in after-market trading following raised guidance for fiscal 2027.

26 août 2026, 23:02 UTC

News

Apple Inc shares are lower in after-market hours, reflecting a decline since Wednesday's close amid broader market pressures from PCE price index data.

26 août 2026, 23:02 UTC

Social Media
Event
Correlated Moves
News

Veeva Systems reported strong Q2 results, raising fiscal 2027 EPS guidance to $9.21. Shares moved higher in after-hours trading following the announcements.

26 août 2026, 23:02 UTC

News
Social Media

Okta Inc reported strong Q2 results, with revenue of $805 million and adjusted EPS of $1.05, driving shares higher in after-market trading.

26 août 2026, 23:02 UTC

Social Media
News

Urban Outfitters shares are lower after reporting fiscal Q2 results, with adjusted earnings per share of $1.72 missing estimates of $1.73.

26 août 2026, 23:02 UTC

Correlated Moves
News

KLA Corp shares are higher in after-market trading, supported by increased demand for process-control systems and positive trends in the semiconductor sector.

26 août 2026, 23:02 UTC

News

Agilent Technologies reported Q3 revenue of $1.88 billion, exceeding estimates. Shares are trading higher in after-market hours following the raised full-year guidance.

26 août 2026, 23:02 UTC

Correlated Moves
News
Social Media

Nutanix shares rose in after-hours trading following strong fourth-quarter results, with revenue of $757.1 million and adjusted EPS of $0.60 exceeding estimates.

26 août 2026, 23:02 UTC

News
Social Media
Event

NVIDIA Corp's stock rose in after-market trading after reporting Q2 revenue of $96.22 billion, exceeding estimates, and providing strong Q3 guidance.

26 août 2026, 23:02 UTC

News

Union Pacific and Norfolk Southern assert merger compliance with STB standards, presenting evidence of public benefits. Shares are trading higher in after-market hours.

26 août 2026, 23:02 UTC

Correlated Moves
News

Corning Inc's shares rise in after-market trading, supported by overall market strength and a positive options market outlook. The Nasdaq 100 Index also increased.

26 août 2026, 23:02 UTC

News
Social Media

CrowdStrike Holdings reported second-quarter revenue of $1.47 billion, exceeding expectations. The stock moved higher in after-market trading following strong guidance and record ARR.

26 août 2026, 23:02 UTC

News
Social Media

Salesforce Inc reported second-quarter earnings of $5.90 per share, exceeding estimates. The company raised fiscal 2027 revenue guidance, driving shares higher in after-market trading.

26 août 2026, 23:02 UTC

Correlated Moves
Social Media
News

Tenable Holdings will join the S&P SmallCap 600 effective August 31, boosting investor interest and contributing to higher after-market trading.

26 août 2026, 23:02 UTC

News
Social Media
Event

Synopsys shares fell in after-hours trading despite strong Q3 results and raised full-year guidance, reflecting investor disappointment over limited upside potential.

26 août 2026, 23:02 UTC

Event
News
Social Media

HP Inc. shares fell in after-hours trading following fiscal Q3 results, which showed net earnings declining to $661 million despite revenue growth to $15.7 billion.

26 août 2026, 23:02 UTC

Correlated Moves
News

Lam Research Corp broke ground on a new R&D facility in Oregon, part of a $3 billion expansion plan, as shares rise in after-market trading.

26 août 2026, 23:02 UTC

News

Lumen Technologies expands Multi-Cloud Gateway access to over 10 million U.S. locations. Shares are trading higher in after-market hours following the announcement.

26 août 2026, 23:02 UTC

Correlated Moves
Social Media
News

BWX Technologies will deploy its Advanced Nuclear Reactor technology for the U.S. Army's Janus program, with shares rising in after-market trading.

26 août 2026, 23:01 UTC

News

Verra Mobility Corp expanded its technology partnership with Hertz through a renewed five-year contract. Shares are trading higher in after-market hours.

Comparaison

Variation de prix

Hutchison China MediTech Ltd ADR prévision

Objectif de Prix

By TipRanks

18.52% hausse

Prévisions sur 12 Mois

Moyen 14.53 USD  18.52%

Haut 16 USD

Bas 13.6 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

1

Achat

2

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat